Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiunn H Lin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Drug Metabolism|February 20, 2007
Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapyJiunn H Lin
Current Drug Metabolism|February 4, 2006
Tissue distribution and pharmacodynamics: a complicated relationshipJiunn H Lin
Advanced Drug Delivery Reviews|January 22, 2003
Drug-drug interaction mediated by inhibition and induction of P-glycoproteinJiunn H Lin
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
How significant is the role of P-glycoprotein in drug absorption and brain uptake?Jiunn H Lin
Current Drug Metabolism|June 10, 2008
Applications and limitations of genetically modified mouse models in drug discovery and developmentJiunn H Lin
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Transporter-mediated drug interactions: clinical implications and in vitro assessmentJiunn H Lin
Current Drug Metabolism|August 26, 2009
Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodiesJiunn H Lin
Current Drug Metabolism|January 29, 2008
CSF as a surrogate for assessing CNS exposure: an industrial perspectiveJiunn H Lin
Pharmaceutical Research|May 24, 2006
CYP induction-mediated drug interactions: in vitro assessment and clinical implicationsJiunn H Lin
Drug Metabolism Reviews|January 7, 2004
Clinical relevance of P-glycoprotein in drug therapyJiunn H Lin, Masayo Yamazaki
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Drug Metabolism|February 20, 2007
Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapyJiunn H Lin
Current Drug Metabolism|February 4, 2006
Tissue distribution and pharmacodynamics: a complicated relationshipJiunn H Lin
Advanced Drug Delivery Reviews|January 22, 2003
Drug-drug interaction mediated by inhibition and induction of P-glycoproteinJiunn H Lin
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
How significant is the role of P-glycoprotein in drug absorption and brain uptake?Jiunn H Lin
Current Drug Metabolism|June 10, 2008
Applications and limitations of genetically modified mouse models in drug discovery and developmentJiunn H Lin
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Transporter-mediated drug interactions: clinical implications and in vitro assessmentJiunn H Lin
Current Drug Metabolism|August 26, 2009
Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodiesJiunn H Lin
Current Drug Metabolism|January 29, 2008
CSF as a surrogate for assessing CNS exposure: an industrial perspectiveJiunn H Lin
Pharmaceutical Research|May 24, 2006
CYP induction-mediated drug interactions: in vitro assessment and clinical implicationsJiunn H Lin
Drug Metabolism Reviews|January 7, 2004
Clinical relevance of P-glycoprotein in drug therapyJiunn H Lin, Masayo Yamazaki
Pageof 5